Natural Investments LLC acquired a new position in shares of The Allstate Co. (NYSE:ALL – Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 6,226 shares of the insurance provider’s stock, valued at approximately $1,200,000.
Other large investors have also recently bought and sold shares of the company. FSA Wealth Management LLC bought a new position in shares of Allstate in the third quarter worth about $26,000. Vision Financial Markets LLC bought a new position in Allstate during the 4th quarter worth approximately $29,000. Peoples Bank KS bought a new position in Allstate during the 4th quarter worth approximately $49,000. Stonebridge Financial Group LLC bought a new position in Allstate during the 4th quarter worth approximately $53,000. Finally, Golden State Wealth Management LLC acquired a new stake in shares of Allstate during the 4th quarter worth approximately $57,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Allstate
In other news, CFO Jesse E. Merten sold 40,102 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the completion of the transaction, the chief financial officer now directly owns 18,115 shares in the company, valued at $3,378,990.95. This trade represents a 68.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.80% of the company’s stock.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on ALL
Allstate Stock Performance
NYSE:ALL opened at $202.25 on Wednesday. The firm has a market cap of $53.60 billion, a PE ratio of 11.90, a price-to-earnings-growth ratio of 1.01 and a beta of 0.47. The Allstate Co. has a fifty-two week low of $156.66 and a fifty-two week high of $209.88. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36. The business has a 50 day moving average price of $191.08 and a 200-day moving average price of $192.10.
Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, topping analysts’ consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. Equities research analysts predict that The Allstate Co. will post 18.74 earnings per share for the current year.
Allstate announced that its board has approved a stock repurchase program on Wednesday, February 26th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the insurance provider to purchase up to 3% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board believes its shares are undervalued.
Allstate Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th will be given a dividend of $1.00 per share. The ex-dividend date is Monday, March 10th. This represents a $4.00 annualized dividend and a yield of 1.98%. This is a positive change from Allstate’s previous quarterly dividend of $0.92. Allstate’s dividend payout ratio (DPR) is currently 23.54%.
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
- Five stocks we like better than Allstate
- What is the Nasdaq? Complete Overview with History
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Breakout Stocks: What They Are and How to Identify Them
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Stock Analyst Ratings and Canadian Analyst Ratings
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.